(CMMB) Chemomab Therapeutics - Performance 69.7% in 12m
Compare CMMB with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-63.85%
#91 in Group
Rel. Strength
95.14%
#388 in Universe
Total Return 12m
69.66%
#13 in Group
Total Return 5y
-93.04%
#118 in Group
P/E -
(?) Percentile in Group
P/E Forward 13.0
47th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: CMMB (69.7%) vs XBI (-12.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: CMMB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CMMB
Total Return (including Dividends) | CMMB | XBI | S&P 500 |
---|---|---|---|
1 Month | 28.13% | 11.81% | 13.81% |
3 Months | -38.19% | -13.61% | -6.30% |
12 Months | 69.66% | -12.29% | 10.65% |
5 Years | -93.04% | -24.89% | 107.77% |
Trend Score (consistency of price movement) | CMMB | XBI | S&P 500 |
1 Month | 76.5% | 72.9% | 83% |
3 Months | -68.6% | -83% | -75.3% |
12 Months | 41.6% | -51.6% | 50.1% |
5 Years | -87.2% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #26 | 14.6% | 12.6% |
3 Month | #150 | -28.5% | -34.0% |
12 Month | #13 | 93.4% | 53.3% |
5 Years | #120 | -90.7% | -96.7% |
FAQs
Does CMMB Chemomab Therapeutics outperforms the market?
Yes,
over the last 12 months CMMB made 69.66%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months CMMB made -38.19%, while XBI made -13.61%.
Over the last 3 months CMMB made -38.19%, while XBI made -13.61%.
Performance Comparison CMMB vs Indeces and Sectors
CMMB vs. Indices CMMB is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -11.4% | 14.3% | -11.4% | 59.0% |
US NASDAQ 100 | QQQ | -11.6% | 10.8% | -11.6% | 58.0% |
US Dow Jones Industrial 30 | DIA | -11.8% | 18.1% | -11.1% | 62.0% |
German DAX 40 | DAX | -11.4% | 13.2% | -37.7% | 44.0% |
Shanghai Shenzhen CSI 300 | CSI 300 | -13.6% | 16.3% | -12.2% | 62.3% |
Hongkong Hang Seng | HSI | -14.6% | 8.20% | -19.8% | 56.0% |
India NIFTY 50 | INDA | -6.48% | 23.3% | -11.8% | 69.9% |
Brasil Bovespa | EWZ | -12.5% | 10.9% | -20.1% | 78.0% |
CMMB vs. Sectors CMMB is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -12.0% | 14.7% | -18.5% | 48.1% |
Consumer Discretionary | XLY | -11.8% | 13.9% | -10.4% | 55.4% |
Consumer Staples | XLP | -10.5% | 21.5% | -18.3% | 60.5% |
Energy | XLE | -11.2% | 21.4% | -4.80% | 79.1% |
Financial | XLF | -12.5% | 14.6% | -18.5% | 47.2% |
Health Care | XLV | -8.39% | 27.3% | -6.40% | 73.7% |
Industrial | XLI | -13.1% | 11.3% | -12.8% | 58.7% |
Materials | XLB | -11.2% | 14.6% | -6.50% | 74.9% |
Real Estate | XLRE | -10.1% | 16.6% | -12.1% | 54.2% |
Technology | XLK | -12.5% | 6.91% | -8.51% | 62.6% |
Utilities | XLU | -11.5% | 18.5% | -19.1% | 52.2% |
Aerospace & Defense | XAR | -13.4% | 6.97% | -22.9% | 42.3% |
Biotech | XBI | -4.81% | 16.3% | 8.75% | 82.0% |
Homebuilder | XHB | -11.9% | 16.7% | 1.80% | 77.2% |
Retail | XRT | -13.3% | 13.5% | -7.15% | 71.1% |